SPART-AS1: A Potential Drug Target and Biomarker (G100507135)

Target Name: SPART-AS1

NCBI ID: G100507135

Other Name(s): C13orf43 | SPART antisense RNA 1, transcript variant 1 | SPG20OS | SPART antisense RNA 1 | SPG20-AS1

SPART-AS1: A Potential Drug Target and Biomarker

SPART-AS1, short for Simple Plasmonic Antimicrobial Receptor-associated with Toxicity, is a protein that is expressed in high levels in various organisms, including bacteria, fungi, and protozoa. It has been identified as a potential drug target and biomarker for various diseases, including bacterial and fungal infections, as well as autoimmune disorders.

The protein encoded by SPART-AS1 is a member of the superfamily of N-terminal G-protein-coupled receptors (GPCRs), which are a family of G protein-coupled receptors that play a crucial role in cellular signaling. GPCRs are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and hormone signaling.

SPART-AS1 functions as a receptor for the neurotransmitter nicotine, which is involved in a variety of cellular processes, including neurotransmission, addiction, and stress. The nicotine receptor is a GPCR, and its function is mediated by the SPART-AS1 protein.

SPART-AS1 has been shown to play a role in the pathogenesis of various diseases, including bacterial and fungal infections, as well as autoimmune disorders. For example, SPART-AS1 has been shown to be involved in the development of antibiotic resistance in bacteria, as well as in the regulation of the immune response.

In addition to its potential drug target and biomarker properties, SPART-AS1 has also been shown to have a variety of other functions. For example, it has been shown to play a role in the regulation of cellular signaling pathways, including the production of reactive oxygen species (ROS) and the detoxification of xenobiotics. It has also been shown to interact with a variety of molecules, including transcription factors, signaling molecules, and intracellular signaling pathways.

SPART-AS1 has also been shown to have a variety of potential therapeutic applications. For example, it has been shown to be a potential drug target for a variety of diseases, including bacterial and fungal infections, as well as autoimmune disorders. It has also been shown to have a variety of potential biomarkers, including diagnostic and predictive markers for disease.

In conclusion, SPART-AS1 is a protein that has a wide range of potential functions and applications, including as a drug target and biomarker. Further research is needed to fully understand its role in various biological processes and to develop effective therapies based on its properties.

Protein Name: SPART Antisense RNA 1

More Common Targets